Caroline Jochems

14PUBLICATIONS
51CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MechanobiologyBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 02, 2025
Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy.

Lisa K Poppe, Nicholas Roller, Miriam Marlene Medina-Enriquez

|May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.

Filipa Lynce, Candace Mainor, Renee N Donahue

|Mar 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.

Filipa Lynce, Candace Mainor, Renee N Donahue

|Jan 14, 2023
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.

Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss

|Apr 14, 2022
Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa.

Yo-Ting Tsai, Julius Strauss, Nicole J Toney

|Mar 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.

Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg

Pageof 3

Frequent Collaborators

14 joint publications

Jeffrey Schlom

6 joint publications

James L Gulley

4 joint publications

Marijo Bilusic

3 joint publications

Renee N Donahue